IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Abingworth LLP

Q3 2020 Holdings

Filed 2020-11-16 | 17 holdings | $467.5K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Vaxcyte(PCVX)Common92243G108$205.9K4,168,71844.0%
Personalis(PSNL)Common71535D106$96.7K4,462,45220.7%
Phathom(PHAT)Common71722W107$44.5K1,203,1359.5%
SolenoCommon834203200$25.8K10,302,6025.5%
Crispr(CRSP)NAMEN AKTH17182108$21.7K259,5994.6%
NucanaADS67022C106$17.2K3,333,3333.7%
Verona(VRNA)SPONDS ADR925050106$15.3K2,457,4993.3%
Exicure(XCUR)Common30205M101$12.1K6,977,0002.6%
Sierra OncologyCommon82640U107$9.2K876,5412.0%
SientraCommon82621J105$8.1K2,390,8431.7%
ParatekCommon699374302$5.6K1,041,1311.2%
Molecular TemplatesCommon608550109$2.2K200,0000.5%
Aeglea(AGLEUSD)Common00773J103$1.7K240,5000.4%
Cymabay(CBAYUSD)Common23257D103$947131,0360.2%
ProtaraCommon74371L109$34420,6100.1%
ObsevaCommonH5861P103$21887,9990.0%
OcugenCommon43358V109$27,1110.0%